Seaport Therapeutics Financials - Benzinga

SPY763.39+0.10%QQQ740.98+0.16%BTC/USD83,655.10+0.03%DIA508.91+0.07%GLD381.32+0.13%TLT77.73−0.07%

Seaport Therapeutics Inc

SPTXNASDAQ

Trade with Public

Trade with Public

$20.17

1.487.92%

At close: Sep 30, 5:00 PM EST

$20.17

N/A

After Hours: 4:00 PM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Stock Report

Seaport Therapeutics Financials

Seaport Therapeutics (SPTX) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Seaport Therapeutics Q2 EPS $(1.78) Misses $(0.65) Estimate

Seaport Therapeutics (NASDAQ:SPTX) reported quarterly losses of $(1.78) per share which missed the analyst consensus estimate of $(0.65) by 173.85 percent. This is a 72.19 percent increase over losses of $(6.40) per

Benzinga Newsdesk

PRO
Seaport Therapeutics Q1 EPS $(10.34) Misses $(9.48) Estimate

Seaport Therapeutics (NASDAQ:SPTX) reported quarterly losses of $(10.34) per share which missed the analyst consensus estimate of $(9.48) by 9.07 percent.

Benzinga Newsdesk